Insights On Outsourced Drug Development
-
Addressing Raw Material Handling Challenges By Dry Granulation
8/12/2025
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Sustainability In On-Body Delivery System Platforms
7/2/2026
Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.
-
The Continuing Challenge Of Drug-Induced Liver Injury
9/24/2026
Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success
2/26/2025
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions
11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
-
Key Metrics In Antibody Drug Development
6/26/2025
Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
-
Scientific Data Is Not AI‑Ready By Default
6/26/2026
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
Practical Formulation Strategies For Poorly Soluble APIs
10/2/2026
Poor aqueous solubility now defines most drug candidates in development, making early screening and solid-state assessment essential to achieving reliable exposure and avoiding costly reformulation downstream.
-
How To Achieve Late-Phase Success In Complex OSD Development
8/31/2026
Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
7/29/2025
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.